The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
Published: October 27, 2021 at 12:00PM
from NYT Health https://ift.tt/3jCHnBJ
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
Published: October 27, 2021 at 12:00PM
from NYT Health https://ift.tt/3jCHnBJ